Catalyst Wire Dossier Catalyst Wire Dossier

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION

neomycin and polymyxin B sulfates and hydrocortisone otic suspension · Rising Pharma Holdings, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION, covering 2017-12-19 to 2019-03-15. Get the full timeline:

Most recent: FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION — Supplemental Application (Rising Pharma Holdings, Inc.)

See pricing